Zevra Therapeutics ZVRA
NASDAQ ZVRA
$9.99 -0.19 (-1.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Interest & Investment Income (2014 - 2026)

Updated

Zevra Therapeutics (ZVRA) posted Interest & Investment Income of $2.57 million for Q2 2026, up 7.9% from $2.38 million a year earlier but down 28.5% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Interest & Investment Income (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Zevra Therapeutics was $10.18 million, up 161.2% year-over-year; for FY2025, it came in at $6.95 million, up 219.4% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 139.0% (FY2020 to FY2025).
  • In prior years, Zevra Therapeutics' Interest & Investment Income was $2.18 million in FY2024 (-52.1%), $4.54 million in FY2023 (+200.1%), $1.51 million in FY2022 (+479.7%) and $261,000 in FY2021 (+193.3%).
  • Quarterly Interest & Investment Income has run from a low of -$73,000 in Q4 2024 to a high of $3.59 million in Q1 2026 over five years.
  • On a year-over-year basis, Interest & Investment Income increased in four of the last six quarters, with growth averaging 231.5%.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q1 2023, with growth of 873.8%; the weakest was Q2 2024, with a decline of 82.6%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $3.59 million (Q1 2026), $1.71 million (Q4 2025) and $2.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Zevra Therapeutics 592.83 Mn -219.88 Mn 38.18 Mn 2.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.57 Mn
Mar 31, 2026 3.59 Mn
Dec 31, 2025 1.71 Mn
Sep 30, 2025 2.31 Mn
Jun 30, 2025 2.38 Mn
Mar 31, 2025 543,000.00
Dec 31, 2024 -73,000.00
Sep 30, 2024 1.05 Mn
Jun 30, 2024 270,000.00
Mar 31, 2024 929,000.00
Dec 31, 2023 210,000.00
Sep 30, 2023 1.74 Mn
Jun 30, 2023 1.55 Mn
Mar 31, 2023 1.04 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 218,000.00
Jun 30, 2022 366,000.00
Mar 31, 2022 107,000.00
Dec 31, 2021 125,000.00
Sep 30, 2021 137,000.00
API Access

Zevra Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ZVRA&period=max&api_key=YOUR_API_KEY